Carmignac Gestion »

Horizon Therapeutics shares owned by Carmignac Gestion

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Carmignac Gestion from 13F filings

Historical chart of Carmignac Gestion investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Carmignac Gestion consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Carmignac Gestion

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.9M 68k 115.69
2023-06-30 $3.8M 37k 102.85

More positions owned by Carmignac Gestion

Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
NVIDIA Corporation (NVDA)
S&p Global (SPGI)
Intercontinental Exchange (ICE)
Alibaba Group Holding Sponsored Ads (BABA)
Alphabet Cap Stk Cl A (GOOGL)
Baxter International (BAX)
Metropcs Communications (TMUS)
General Electric (GE)
Schlumberger Com Stk (SLB)
Humana (HUM)

View all positions for Carmignac Gestion

Top funds holding Horizon Therapeutics

IFP Advisors
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics